Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Microbiol Infect ; 20(11): O854-6, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24602145

RESUMO

We examined whether quantitative biofilm formation and/or lipopolysaccharide type of Burkholderia pseudomallei was associated with relapsing melioidosis. We devised a 1:4 nested case-control study in which both cases and controls were drawn from a cohort of patients with primary melioidosis. Paired isolates from 80 patients with relapse and single isolates from 184 patients without relapse were tested. Relapse was associated with biofilm formation of the primary infecting isolate (conditional OR 2.03; 95% CI 1.27-3.25; p 0.003), but not with lipopolysaccharide type (p 0.74). This finding highlights the importance of biofilm formation in relapsing melioidosis.


Assuntos
Biofilmes/crescimento & desenvolvimento , Burkholderia pseudomallei/fisiologia , Lipopolissacarídeos/metabolismo , Melioidose/microbiologia , Adulto , Estudos de Casos e Controles , Feminino , Humanos , Lipopolissacarídeos/química , Masculino , Pessoa de Meia-Idade , Recidiva
2.
Asian Pac J Cancer Prev ; 10(4): 575-82, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19827872

RESUMO

Runt-related transcription factor 3 (RUNX3) is a candidate tumor suppressor gene, localized on 1p36, involved in TGF-beta-Smads signaling. To assess its role in liver fluke-associated intrahepatic cholangiocarcinoma (ICC), the promoter methylation status was investigated in 53 ICCs by methylation-specific PCR, with determination of loss of 1p36.1 by microarray comparative genomic hybridization and RUNX3 protein expression by immunohistochemistry. Loss at 1p36.1 was found 41.5% of ICCs (22/53). In addition, DNA hypermethylation of the RUNX3 promoter was found in 49.1% (26/53) of cancers and 57.1% (4/7) of ICC cell lines. The protein was highly expressed in normal bile ducts but mostly decreased in ICCs, 67.9% (n= 36) being negative for immunohistochemical staining. Promoter hypermethylation of RUNX3 was associated with reversible decrease or absence of RUNX3 protein expression (p<0.001), but this was not found to differ with the ICC subtype. In contrast, loss of 1p36.1 demonstrated a significant link (p= 0.020). In conclusion, RUNX3 promoter hypermethylation and loss of 1p36.1 are causal mechanisms for loss of RUNX3 function in liver fluke-associated ICC carcinogenesis.


Assuntos
Neoplasias dos Ductos Biliares/genética , Colangiocarcinoma/genética , Cromossomos Humanos Par 1/genética , Subunidade alfa 3 de Fator de Ligação ao Core/genética , Metilação de DNA , Fasciolíase/genética , Dosagem de Genes , Animais , Antimetabólitos Antineoplásicos/farmacologia , Azacitidina/farmacologia , Neoplasias dos Ductos Biliares/parasitologia , Neoplasias dos Ductos Biliares/patologia , Ductos Biliares Intra-Hepáticos , Colangiocarcinoma/parasitologia , Colangiocarcinoma/patologia , Hibridização Genômica Comparativa , Fasciola hepatica/isolamento & purificação , Fasciolíase/parasitologia , Fasciolíase/patologia , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Técnicas Imunoenzimáticas , Perda de Heterozigosidade , Masculino , Pessoa de Meia-Idade , Análise de Sequência com Séries de Oligonucleotídeos , Reação em Cadeia da Polimerase , Regiões Promotoras Genéticas/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...